##gff-version 3
##sequence-region O43541 1 496
O43541	UniProtKB	Chain	1	496	.	.	.	ID=PRO_0000090869;Note=Mothers against decapentaplegic homolog 6	
O43541	UniProtKB	Domain	148	275	.	.	.	Note=MH1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00438	
O43541	UniProtKB	Domain	331	496	.	.	.	Note=MH2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00439	
O43541	UniProtKB	Compositional bias	25	33	.	.	.	Note=Poly-Gly	
O43541	UniProtKB	Compositional bias	82	85	.	.	.	Note=Poly-Arg	
O43541	UniProtKB	Compositional bias	165	168	.	.	.	Note=Poly-Leu	
O43541	UniProtKB	Compositional bias	251	254	.	.	.	Note=Poly-Ala	
O43541	UniProtKB	Compositional bias	275	278	.	.	.	Note=Poly-Pro	
O43541	UniProtKB	Metal binding	205	205	.	.	.	Note=Zinc;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O43541	UniProtKB	Metal binding	247	247	.	.	.	Note=Zinc;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O43541	UniProtKB	Metal binding	260	260	.	.	.	Note=Zinc;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O43541	UniProtKB	Metal binding	265	265	.	.	.	Note=Zinc;Ontology_term=ECO:0000250;evidence=ECO:0000250	
O43541	UniProtKB	Modified residue	75	75	.	.	.	Note=Dimethylated arginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35182	
O43541	UniProtKB	Modified residue	75	75	.	.	.	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35182	
O43541	UniProtKB	Modified residue	82	82	.	.	.	Note=Dimethylated arginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35182	
O43541	UniProtKB	Modified residue	82	82	.	.	.	Note=Omega-N-methylarginine%3B alternate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35182	
O43541	UniProtKB	Modified residue	435	435	.	.	.	Note=Phosphoserine%3B by PRKX%3B in vitro;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00439,ECO:0000269|PubMed:16491121;Dbxref=PMID:16491121	
O43541	UniProtKB	Cross-link	173	173	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23455153;Dbxref=PMID:23455153	
O43541	UniProtKB	Alternative sequence	1	261	.	.	.	ID=VSP_006179;Note=In isoform B. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:8673135;Dbxref=PMID:8673135	
O43541	UniProtKB	Alternative sequence	262	273	.	.	.	ID=VSP_006180;Note=In isoform B. NPYHFSRLCGPE->MSRMGKPIETQK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:8673135;Dbxref=PMID:8673135	
O43541	UniProtKB	Alternative sequence	318	338	.	.	.	ID=VSP_035489;Note=In isoform D. DASMSPDATKPSHWCSVAYWE->AADAGIGSRGNRGLESSVPCS;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.5	
O43541	UniProtKB	Alternative sequence	339	496	.	.	.	ID=VSP_035490;Note=In isoform D. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.5	
O43541	UniProtKB	Natural variant	223	496	.	.	.	ID=VAR_078924;Note=In CRS7%3B associated with disease susceptibility. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=PMID:27606499	
O43541	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_078925;Note=In CRS7%3B associated with disease susceptibility. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=dbSNP:rs570279865,PMID:27606499	
O43541	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_077592;Note=In CRS7%3B associated with disease susceptibility. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=PMID:27606499	
O43541	UniProtKB	Natural variant	323	323	.	.	.	ID=VAR_077593;Note=In CRS7%3B associated with disease susceptibility. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=dbSNP:rs1374099442,PMID:27606499	
O43541	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_068074;Note=Found in a patient with congenital mitral valve prolapse. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22275001;Dbxref=dbSNP:rs199822239,PMID:22275001	
O43541	UniProtKB	Natural variant	374	496	.	.	.	ID=VAR_078926;Note=In CRS7%3B associated with disease susceptibility. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=PMID:27606499	
O43541	UniProtKB	Natural variant	390	390	.	.	.	ID=VAR_077594;Note=In CRS7%3B associated with disease susceptibility%3B de novo mutation. G->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=PMID:27606499	
O43541	UniProtKB	Natural variant	407	496	.	.	.	ID=VAR_078927;Note=In CRS7%3B associated with disease susceptibility. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=PMID:27606499	
O43541	UniProtKB	Natural variant	415	415	.	.	.	ID=VAR_068075;Note=In AOVD2%3B results in significantly lower activity than wild-type in inhibiting BMP signaling in a transcriptional reporter assay. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22275001;Dbxref=dbSNP:rs387907284,PMID:22275001	
O43541	UniProtKB	Natural variant	465	465	.	.	.	ID=VAR_077595;Note=In CRS7%3B associated with disease susceptibility. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=dbSNP:rs761888345,PMID:27606499	
O43541	UniProtKB	Natural variant	484	484	.	.	.	ID=VAR_068076;Note=In AOVD2%3B results in significantly lower activity than wild-type in inhibiting BMP signaling in a transcriptional reporter assay. C->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22275001;Dbxref=dbSNP:rs387907283,PMID:22275001	
O43541	UniProtKB	Natural variant	490	490	.	.	.	ID=VAR_078928;Note=In CRS7%3B associated with disease susceptibility. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27606499;Dbxref=dbSNP:rs1338294058,PMID:27606499	
O43541	UniProtKB	Mutagenesis	173	173	.	.	.	Note=Abolishes monoubiquitination by UBE2O. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23455153;Dbxref=PMID:23455153	
O43541	UniProtKB	Mutagenesis	435	435	.	.	.	Note=Loss of in vitro phosphorylation by PRKX. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16491121;Dbxref=PMID:16491121	
O43541	UniProtKB	Mutagenesis	471	471	.	.	.	Note=Loss of SMAD1-binding and of inhibition of BMP-SMAD1 signaling. No effect on interaction with BMPR1B and TGFBR1. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9436979;Dbxref=PMID:9436979	
O43541	UniProtKB	Mutagenesis	478	496	.	.	.	Note=Loss of interaction with BMPR1B%2C TGFBR1 and SMAD1. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9436979;Dbxref=PMID:9436979	
O43541	UniProtKB	Sequence conflict	21	21	.	.	.	Note=D->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
